Cytokinetics Balance Sheet Health
Financial Health criteria checks 2/6
Cytokinetics has a total shareholder equity of $-13.9M and total debt of $774.6M, which brings its debt-to-equity ratio to -5568.4%. Its total assets and total liabilities are $1.4B and $1.4B respectively.
Key information
-5,568.4%
Debt to equity ratio
US$774.62m
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.01b |
| Equity | -US$13.91m |
| Total liabilities | US$1.45b |
| Total assets | US$1.44b |
Recent financial health updates
Recent updates
Cytokinetics: On The Cusp Of Commercialization
Nov 14Cytokinetics: Aficamten Rolling NDA Submission Leads To Expansion Opportunities
Aug 13Is Cytokinetics (NASDAQ:CYTK) Weighed On By Its Debt Load?
Aug 11
Cytokinetics' Aficamten: Heartfelt Potential Amid Market Woes
Jul 24Cytokinetics Decides To Go It Alone
May 24Here's Why We Think Cytokinetics, Incorporated's (NASDAQ:CYTK) CEO Compensation Looks Fair for the time being
May 09Cytokinetics, Incorporated: Buyout Speculation Persists
Apr 01Cytokinetics: CEO Talks Down Buyout Prospects
Mar 16Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)
Jan 12Financial Position Analysis
Short Term Liabilities: CYTK has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: CYTK has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: CYTK has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: CYTK's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYTK has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CYTK has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 34.9% each year.